SIS
COGT icon

Sound Income Strategies’s Cogent Biosciences COGT Stock Holding History

Sound Income Strategies’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-96
Closed -$3.38K – 846
2026
Q1 		$3.38K Buy
+96
New +$3.54K ﹤0.01% 1992

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Sound Income Strategies's COGT Position: Q2 2026 in Review

Sound Income Strategies sold out of Cogent Biosciences (COGT) in Q2 2026, closing a stake of 96 shares — an estimated $3.38K sold.

Sound Income Strategies first reported a position in COGT in Q1 2026 and held it in 1 quarter. The position peaked at $3.38K in Q1 2026. 35 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Sound Income Strategies reported no remaining Cogent Biosciences position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 96 Cogent Biosciences shares in Q2 2026, an estimated $3.38K.
  • Sound Income Strategies first reported a position in Cogent Biosciences in Q1 2026 and held it in 1 quarter.
  • Sound Income Strategies's Cogent Biosciences position peaked at $3.38K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.